|
|
Regency A
| |||
D3: D3 - Hepatitis Infection in IDUs: Current Epidemiologic Trends | |||
| In this session, an overview of hepatitis epidemiology among IDUs will be shared, followed by results from research projects looking at viral hepatitis A, B and C among IDUs. Risk behaviors and preventive care acceptance (e.g. vaccine) will be discussed. | |||
| Learning Objectives: A. Outline strategies for hepatitis prevention for infants, children, adolescents, and adults.
B. Identify specific intervention strategies that address the needs of individuals in high-risk groups including, but not limited to, infants born to HBsAg-positive mothers, clients engaged in injection drug use (IDU)/substance abuse, clients in STD/HIV clinics, men who have sex with men, homeless populations, and inmates in correctional settings.
| |||
| Moderator: | Ian T. Williams | ||
| 10:30 AM | 69 | Hepatitis A and B virus (HAV and HBV) seroprevalence and structural factors associated with vaccine uptake among younger injection drug users (IDUs) in 5 U.S. cities Cindy Weinbaum, Jennifer V. Campbell, Richard S. Garfein, Elizabeth T. Golub, Lawrence J. Ouellet, Sharon M. Hudson, Danielle C. Ompad, Hanne Thiede | |
| 11:00 AM | 70 | Trends in Hepatitis B and C Seroprevalence in Young Seattle-Area Injection Drug Users Richard Burt, Hanne Thiede, Holly Hagan | |
| 11:30 AM | 71 | Awareness of hepatitis C virus serostatus and risk behavior in young injection drug users in 5 US cities Holly Hagan, Jennifer V. Campbell, Hanne Thiede, Steffanie Strathdee, Lawrence J. Ouellet, Farzana Kapadia, Sharon M. Hudson, Richard S. Garfein | |
The 2005 National Viral Hepatitis Prevention Conference of CDC